Viz.ai and Cortechs.ai are collaborating to integrate Cortechs.ai's NeuroQuant MS quantitative MRI analysis suite into the Viz.ai care coordination platform.
The integration will enable clinicians to access quantitative MRI analysis for multiple sclerosis (MS) directly within Viz.ai's care coordination workflow, according to the companies. Viz.ai said the partnership marks its expansion into neurodegenerative disease, growing its Viz Neuro Suite beyond its existing neurological offerings. The company said additional partnership and product announcements focused on neurodegenerative diseases are expected in the near future.
Viz.ai's platform is currently deployed at nearly 2,000 U.S. hospitals, according to the company.
